Trusted Ratings
Our rating system
Our system evaluates ratings based on the overall user experience, including website responsiveness, after-sales support, refund policies, and similar factors. Some reviews are sourced from third-party providers. We also encourage you to share your own experiences with these brands by leaving a review.
Need a featured listing for your business in
Get In Touch With Our Team To Get A Featured Listing of Your Business
About Medvi
MEDVi is a nationwide telehealth platform specializing in affordable, physician-supervised GLP-1 weight loss programs. It focuses on addressing the high cost of brand-name GLP-1 drugs by offering access to cheaper compounded alternatives, including Semaglutide, Liraglutide, and the dual-action Tirzepatide, available in various formats like injections, tablets, or oral drops.
Pros of Medvi
- Offers a single, transparent monthly fee that covers medication, consultation, labs, and shipping.
- Provides a strong 20% weight loss guarantee after four months, offering a financial safety net.
- Offers choice between injections and oral/sublingual tablets for compounded medications.
Cons of Medvi
- Relies entirely on compounded GLP-1s, which lack specific FDA approval for safety and efficacy.
- Does not offer or process insurance for FDA-approved brand-name drugs (Wegovy, Zepbound).
- Some reports of initial billing friction and slow customer service response times.
Plans and Pricing
MEDVi’s weight loss program operates on a straightforward, cash-pay subscription model, ensuring price transparency without the hassle of insurance. The introductory cost for the most popular plan, compounded GLP-1 injections (Semaglutide/Tirzepatide), is set at a discounted rate of $179 for the first month. After this initial period, the cost is locked in at $299 per month for refills. This all-inclusive membership covers the prescription medication, supplies, physician consultation, personalized plan, metabolic report, and free shipping. They also offer a higher-starting compounded GLP-1 tablet option and occasionally list limited brand-name Ozempic availability at a significantly higher monthly cost.
How It Works
MEDVi utilizes a highly efficient, entirely digital process to deliver affordable, medically-supervised GLP-1 weight loss therapy. The user begins with an online evaluation which is swiftly reviewed by a U.S.-licensed physician to confirm eligibility. Unlike services that prioritize brand names, MEDVi immediately focuses on providing a personalized prescription for compounded GLP-1 medications (Semaglutide or Tirzepatide), available in patient-friendly formats like injections or oral drops/tablets.
Get Approved: The patient starts by completing a quick online medical evaluation. A licensed medical provider from the affiliated network reviews this information to determine eligibility for GLP-1 treatment.
Get Prescribed: If approved, the provider conducts a personalized consultation to create a tailored care plan and issue a prescription for compounded GLP-1 medication, such as Semaglutide or Tirzepatide (available as injections or oral tablets).
Receive Medication: The prescription is fulfilled by a licensed compounding pharmacy, and the medication and supplies are shipped directly to the patient’s door for maximum convenience.
Ongoing Support and Monitoring: The patient manages their journey with continuous support, including unlimited 24/7 access to a dedicated team of clinical specialists for guidance, dosage adjustments, and addressing any concerns.
Is MedVi Safe and Legitimate?
MEDVi is a legitimate telehealth company that provides medically-supervised GLP-1 weight loss programs in compliance with state and federal laws. It is LegiScript certified, confirming that it meets transparency standards and is regularly monitored for compliance. All treatment is provided by U.S.-licensed physicians, and medications are dispensed from licensed, FDA-regulated compounding pharmacies in the U.S. The company reinforces its legitimacy with a strong money-back guarantee and a commitment to 24/7 patient support.
However, the primary safety and legitimacy consideration stems from its reliance on compounded GLP-1 medications (Semaglutide/Tirzepatide). While legal under current drug shortage rules and prepared in regulated facilities, these specific compounded formulations are not evaluated or approved by the FDA for safety, efficacy, or quality. MEDVi is transparent about this, but it introduces an inherent regulatory and clinical risk compared to fully FDA-approved brand-name drugs. Patients should weigh the cost savings and convenience against this compounding caveat.
MedVi Help & Support
MEDVi is built on an all-inclusive support model, where the monthly fee covers continuous patient assistance without extra charges. For clinical needs, patients have access to a licensed medical provider for regular check-ins, dosage adjustments, and prescription management via telehealth.
Crucially, MEDVi offers unlimited 24/7 access to a team of dedicated specialists, ensuring patients can get answers to urgent questions regarding side effects or program logistics at any time. This high level of round-the-clock support is designed to ensure patient confidence and compliance, making the program feel medically guided rather than just transactional. While most patient reviews praise the responsiveness and knowledge of the medical staff, some administrative concerns related to initial scheduling or billing have been noted, though the company actively responds to resolve these public issues.
Clinical Access: Regular virtual check-ins and direct messaging with U.S.-licensed physicians for medical guidance.
24/7 Specialist Team: Unlimited, round-the-clock support for immediate answers to questions and concerns.
Proactive Follow-up: The team tracks progress and provides ongoing medication and coaching health assistance.
MEDVi’s Winning Edge in the GLP-1 Weight Loss Space
MEDVi dominates the cash-pay segment of the GLP-1 market by its focus on high-value assurance and medication flexibility. Unlike competitors who rely on hidden dispensing fees, MEDVi offers a simple, all-inclusive price that covers medication, dosing, and support, making the total cost predictable and highly competitive.
The single biggest differentiator is the money-back guarantee (if a patient doesn’t achieve 20% weight loss after four months), which provides an unparalleled level of confidence and security to the customer. This financial safety net, combined with the option of oral or injectable compounded GLP-1s (including the potent Tirzepatide), positions MEDVi as the most value-driven and results-guaranteed choice for patients prioritizing affordability and concrete success.
Frequently Asked Questions
We’ve got answers to many common questions, but if you need further assistance, our team is ready to provide personalized support. Reach out to us for any additional guidance you may need.